Clinical Trials and Research

NAMSA and Lexitas Partner to Deliver End-to-End Ophthalmic Medical Device Development

Strategic collaboration combines global MedTech development capabilities with specialised ophthalmic expertise to streamline innovation...

Medtronic Advances Affera Platform with Sphere-9 and Sphere-360 Catheter Milestones at Heart Rhythm 2026

New clinical data and regulatory progress highlight growing adoption of pulsed field ablation technologies for complex arrhythmias...

Pulse Biosciences Reports Positive Outcomes for nPulse Cardiac Catheter System at Rhythm 2026

Late-breaking data demonstrate strong durability and procedural efficiency, reinforcing potential of nanosecond pulsed field ablation in atrial fibrillation treatment...

Adagio Medical Reports Positive Pivotal Results for vCLAS Ventricular Ablation System

FULCRUM-VT trial demonstrates strong safety and effectiveness outcomes, supporting potential advancement of ultra-low temperature ablation for complex arrhythmias...

Boston Scientific Highlights Data-Driven Cardiac Therapies at Rhythm 2026

Focus on real-time data insights and connected monitoring underscores shift toward precision cardiac care and improved clinical decision-making...

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP XL

This study provided an imaging based assessment of the closure site and demonstrated encouraging early vascular findings in a high-risk, fully anticoagulated population, offering further insight into vascular healing following VASCADE MVP XL deployment...

Neurava Secures $4M NIH Award to Develop AI-Based SUDEP Risk Stratification Algorithm

Funding will support development of a predictive algorithm integrating multimodal physiological data to enable earlier intervention in epilepsy care...

IHH Healthcare delivers strong growth in 2025 and sets clear course towards 2030 with focus on clinical innovation, patient care and environmental stewardship

IHH outlines 2030 sustainability roadmap as it drives clinical excellence, expands capacity, and advances value-based care across global markets...

Everest Medicines Announces Positive First-in-Human Data for Personalised mRNA Cancer Vaccine EVM16 at AACR 2026

Demonstrating a Favourable Safety Profile, Robust Immunogenicity, and Promising Preliminary Efficacy...

Deloitte launches Asia Pacific Health Institute with new report on technology-enabled healthcare access

Deloitte’s new Asia Pacific Health Institute highlights how digital health, AI, and connected care models can address rising demand, workforce pressures, and uneven access across the region...